Skip to main content
UniHealth

Doctor search

Jay C Wang, MD

Ophthalmology · Monterey

NPI 1225443997

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
34
9 carriers
Offices
5

Offices

5 locations · Northern California Retina Vitreous Associates Medical Group, Inc. · 7 clinicians in this group

Looking this up.

Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.

Plans that list them

34 plans · 9 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

34 of 34 plans

Plans whose provider directory lists this clinician
Alignment Health Advantage PPO (PPO)Alignment Health PlanListedOct 3, 2026
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Sutter Advantage +More (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
Anthem Medicare Advantage (HMO-POS)Anthem Blue CrossListedOct 3, 2026
Anthem Prime (HMO-POS)Anthem Blue Cross Partnership PlanListedOct 3, 2026
Astiva Health C-SNP WOW - NorCal (HMO C-SNP)Astiva HealthListedSep 27, 2026
Astiva Health Premier Plan - NorCal (HMO)Astiva HealthListedSep 27, 2026
Astiva Health Savings Plan - NorCal (HMO)Astiva HealthListedSep 27, 2026
Blue Shield Inspire (HMO)Blue Shield of CaliforniaListedAug 26, 2026
Central Health Classic Care Plan III (HMO)Central Health Medicare PlanListedAug 15, 2026
Central Health Dual Access Plan (HMO D-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Embrace Care Plan (HMO C-SNP)Central Health Medicare PlanListed, may be out of dateSep 15, 2025
Central Health Embrace Choice Plan (HMO C-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Valor Care Plan (HMO)Central Health Medicare PlanListedAug 15, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A174746 · Current

Licensed to practise in California · since 2021 · expires 2027-09-30 · Harvard Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Good Samaritan Hospital
Clostridium Difficile (C.Diff)Infections0.337BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.75 (0 to 1.67) · 1,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.84 (0.54 to 1.14)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths143.59 (98.7 to 188.49) · 98 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.7 · 45 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 100 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.7 · 270 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.3 · 573 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.6 · 820 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.5 · 482 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.3 · 3,711 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.12 (0 to 0.3) · 8,866 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.01 to 0.38) · 9,051 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.65 (0.74 to 4.56) · 1,929 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.8 (0.21 to 3.39) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.33 (0.88 to 3.78) · 1,836 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.73 (0 to 13.46) · 669 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.58 (3.96 to 11.19) · 654 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.59 (0.13 to 3.04) · 496 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.27 (0 to 0.87) · 7,373 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.1 · 152 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections1.08No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.542No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.484No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.565No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 327 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits24.2 · 703 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits61.1 · 289 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits36.3 · 665 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits25.4 · 856 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19 · 978 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits6.3 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.3 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.2 · 135 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.8 (10.1 to 18.6) · 129 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.5) · 531 casesNo differentJan 2024 – Dec 2024

What patients said (704 patients answered, 24% of those asked)

Patient survey stars by topic at Good Samaritan Hospital
Cleanliness3
Nurse communication3
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness1
Recommend hospital3
Share of patients giving the best answer at Good Samaritan Hospital
Room was "always" clean66%
Nurses "always" communicated well75%
Doctors "always" communicated well71%
Staff "always" explained54%
Yes, staff "did" give patients this information83%
Yes, staff "did" give patients information about help after discharge81%
Doctors "always" explained things so they could understand66%
Doctors "always" listened carefully69%
Doctors "always" treated them with courtesy and respect78%
Patients who gave a rating of "9" or "10" (high)63%
Staff "always" explained new medications68%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully73%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night38%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects40%
Yes, staff "did" give patients information about possible symptoms86%

Original Medicare doctor bills

$2,545,422

Medicare paid this office $2,545,422 for 877 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, aflibercept, 1 mg181$1,091,102None
Injection, faricimab-svoa, 0.1 mg95$881,133None
Injection of drug into eye282$146,362$109
Imaging of retina823$95,576$38
Established patient problem focused exam of visual system441$60,316$91
See all 14 services
Every Original Medicare service billed
Injection, aflibercept, 1 mg181$1,091,102None
Injection, faricimab-svoa, 0.1 mg95$881,133None
Injection of drug into eye282$146,362$109
Imaging of retina823$95,576$38
Established patient problem focused exam of visual system441$60,316$91
Established patient complete exam of visual system525$58,759$109
Short return visit (20+ min)213$18,124$65
New patient complete exam of visual system136$17,880$131
Exam of retinal blood vessels using a special camera after injection of a dye96$16,601$161
Return visit (30+ min)97$14,107$116
New patient visit (45+ min)69$10,685$155
Photography of the retina113$4,680$33
Compounded drug, not otherwise classified18$2,815None
2d ultrasound scan of eye tissue and structures25$2,381$48

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery1-10None

Who their Medicare patients are

877 Original Medicare patients in 2024. Average age 78 · Under 65 4% · 85 and older 24% · Women 58% · Also on Medicaid 24% · Health risk score 1.39. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 75% · Diabetes 35% · Coronary heart disease 28% · Chronic kidney disease 23% · Cancer 16% · Atrial fibrillation 16% · Heart failure 15% · Depression 14% · COPD 11% · Stroke 9% · Dementia 7%.

The office billed $7,726,160, Medicare allowed $3,248,093 and paid $2,545,422; for 41,725 services of 46 kinds; $2,052,183 of it was for drugs given in the office and $493,238 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202487741,725781.39$7,726,160$2,545,422
202382725,131781.28$6,783,934$2,329,515
20227319,585781.24$5,555,362$2,001,727
20214071,936761.41$1,278,524$407,154
2020162470712.01$323,276$64,717
2019146246721.71$126,439$22,334
201863101711.01$48,463$10,649

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 17 services

Original Medicare services billed in 2023
Injection, aflibercept, 1 mg209$1,357,796None
Injection, faricimab-svoa, 0.1 mg56$456,928None
Injection of drug into eye276$132,481$104
Imaging of retina791$86,495$37
Short return visit (20+ min)477$59,501$73
Established patient complete exam of visual system230$27,066$116
Exam of retinal blood vessels using a special camera after injection of a dye161$23,513$138
New patient complete exam of visual system176$22,225$126
Repair of detached retina with drainage and removal of eye fluid between lens and retina14$17,963$1,123
New patient visit (45+ min)126$16,717$133
Return visit (30+ min)102$13,691$111
Repair of detached retina by injection of air or gas11$10,225$852
Destruction of leaking blood vessels of retina using laser11$8,279$436
Compounded drug, not otherwise classified20$5,992None
Photography of the retina83$3,474$32
2d ultrasound scan of eye tissue and structures30$2,772$47
Long return visit (40+ min)12$2,035$170

2022: 18 services

Original Medicare services billed in 2022
Injection, aflibercept, 1 mg196$1,465,481None
Injection of drug into eye234$113,217$102
Imaging of retina702$77,289$36
Injection, ranibizumab, 0.1 mg17$62,785None
Injection, faricimab-svoa, 0.1 mg16$59,086None
Short return visit (20+ min)394$56,920$76
New patient complete exam of visual system205$25,143$123
Exam of retinal blood vessels using a special camera after injection of a dye142$19,129$123
New patient visit (45+ min)147$17,303$118
Repair of detached retina with drainage and removal of eye fluid between lens and retina15$15,524$1,035
Established patient complete exam of visual system135$13,453$99
Return visit (30+ min)75$9,216$106
Removal of eye fluid (vitreous) between lens and retina11$9,058$755
Destruction of leaking blood vessels of retina using laser11$5,296$353
Compounded drug, not otherwise classified18$2,877None
Photography of the retina51$2,313$32
New patient visit (60+ min)13$2,029$156
2d ultrasound scan of eye tissue and structures22$1,470$43

2021: 14 services

Original Medicare services billed in 2021
Injection, aflibercept, 1 mg88$263,761None
Injection of drug into eye118$22,877$105
Injection, ranibizumab, 0.1 mg13$21,971None
Imaging of retina305$16,608$37
Short return visit (20+ min)158$15,393$81
Established patient complete exam of visual system101$10,289$100
New patient complete exam of visual system71$8,303$117
Return visit (30+ min)60$7,868$98
New patient visit (45+ min)45$6,761$150
Photography of the retina108$4,501$30
Exam of retinal blood vessels using a special camera after injection of a dye37$4,196$113
Established patient problem focused exam of visual system30$2,565$85
Injection, bevacizumab, 10 mg13$1,300None
2d ultrasound scan of eye tissue and structures13$666$42

2020: 5 services

Original Medicare services billed in 2020
Established patient complete exam of visual system82$12,129$109
Photography of the retina85$4,015$39
New patient complete exam of visual system28$3,637$130
Injection of drug into eye18$3,225$92
Imaging of retina28$1,393$36

2019: 6 services

Original Medicare services billed in 2019
Repair of detached retina with drainage and removal of eye fluid between lens and retina16$2,716$170
Injection of drug into eye25$2,419$97
Established patient complete exam of visual system25$1,791$69
Imaging of retina35$718$20
Emergency department visit with straightforward medical decision making15$456$30
Examination of eye by ophthalmoscope with retinal drawing13$393$30

2018: 3 services

Original Medicare services billed in 2018
Emergency department visit with moderate level of medical decision making12$1,190$99
Emergency department visit with straightforward medical decision making16$522$33
Imaging of retina11$273$23

Medicaid work

$307,875 in 2024

Medicaid paid $307,875 for 2,216 billed services this clinician did in 2024, up to 99 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Aflibercept injection374$251,402
Intravitreal injection of a pharmacologic agent (separate procedure)589$44,904
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina910$7,371
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST129$1,861
Injection, bevacizumab, 10 mg21$860
Short return visit (20+ min)64$740
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient129$738
Medicaid work by year
20242,216799$307,875
20232,680898$384,150
20221,252764$164,379
2021915740$64,184
2020475650$15,155
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Aflibercept injection487$302,242
Intravitreal injection of a pharmacologic agent (separate procedure)673$68,737
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina1,020$8,105
Short return visit (20+ min)399$2,177
Injection, bevacizumab, 10 mg34$1,791
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI41$844
Return visit (30+ min)12$152
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST14$102

2022

Largest Medicaid services in 2022
Aflibercept injection201$126,966
Intravitreal injection of a pharmacologic agent (separate procedure)286$30,432
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina532$3,661
Injection, bevacizumab, 10 mg47$1,772
Short return visit (20+ min)143$786
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI29$706
OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST14$55

2021

Largest Medicaid services in 2021
Aflibercept injection26$33,721
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT281$10,007
Intravitreal injection of a pharmacologic agent (separate procedure)114$8,990
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina279$4,475
Return visit (30+ min)75$2,738
Short return visit (20+ min)99$2,447
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST41$1,806

2020

Largest Medicaid services in 2020
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST168$5,555
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT167$5,125
OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST59$2,398
Intravitreal injection of a pharmacologic agent (separate procedure)21$1,398
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina43$627
Injection, bevacizumab, 10 mg17$52

Drugs they prescribed that Part D paid

$15,769

Pharmacies billed $15,769 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 434) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

293 generic and 141 brand-name prescriptions · $15,769 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Prednisolone Acetate132$4,100$31
Bromfenac22$3,917$178
Ketorolac Tromethamine107$1,900$18
Difluprednate13$1,453$112
Neomycin-Polymyxin-Dexameth78$779$10
See all 7 drugs
Every Part D drug this clinician prescribed
Prednisolone Acetate132$4,100$31
Bromfenac22$3,917$178
Ketorolac Tromethamine107$1,900$18
Difluprednate13$1,453$112
Neomycin-Polymyxin-Dexameth78$779$10
Dorzolamide-Timolol13$124$10
Timolol Maleate16$74$5

Year by year

Part D prescribing by year
20244341120% (0)32%$15,769
202343094None33%$23,291
202233990None31%$17,907
2021199550% (0)41%$21,107
202024588None47%$15,442
2019467160None45%$34,520
2018502179None49%$48,734
201717380None38%$14,593
20166646None27%$4,353
201512758None29%$14,714
20143618NoneNone$1,826

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 9 drugs

Part D drugs prescribed in 2023
Prolensa14$6,187$442
Prednisolone Acetate128$4,986$39
Bromfenac20$3,928$196
Ketorolac Tromethamine87$1,946$22
Neomycin-Polymyxin-Dexameth59$771$13
Dorzolamide-Timolol22$690$31
Dorzolamide26$655$25
Brimonidine11$119$11
Sulfamethoxazole-Trimethoprim11$7$1

2022: 6 drugs

Part D drugs prescribed in 2022
Prednisolone Acetate86$3,154$37
Ketorolac Tromethamine77$2,128$28
Brimonidine22$1,016$46
Neomycin-Polymyxin-Dexameth52$788$15
Dorzolamide-Timolol19$751$40
Dorzolamide26$541$21

2021: 5 drugs

Part D drugs prescribed in 2021
Brimonidine18$2,334$130
Prednisolone Acetate37$1,601$43
Ketorolac Tromethamine52$1,471$28
Dorzolamide-Timolol12$561$47
Latanoprost26$509$20

2020: 6 drugs

Part D drugs prescribed in 2020
Prednisolone Acetate62$2,008$32
Moxifloxacin34$1,583$47
Ketorolac Tromethamine35$1,048$30
Atropine Sulfate24$984$41
Dorzolamide-Timolol18$453$25
Brimonidine17$276$16

2019: 10 drugs

Part D drugs prescribed in 2019
Prednisolone Acetate106$4,366$41
Moxifloxacin51$2,200$43
Brimonidine34$1,673$49
Atropine Sulfate36$1,524$42
Timolol Maleate20$1,217$61
Dorzolamide-Timolol25$995$40
Ketorolac Tromethamine45$779$17
Latanoprost21$227$11
Atorvastatin16$209$13
Erythromycin12$133$11

2018: 12 drugs

Part D drugs prescribed in 2018
Azopt22$6,932$315
Ilevro20$6,064$303
Prednisolone Acetate88$4,997$57
Timolol Maleate38$3,737$98
Moxifloxacin45$2,481$55
Brimonidine24$1,626$68
Ketorolac Tromethamine36$901$25
Latanoprost47$757$16
Atropine Sulfate23$733$32
Dorzolamide16$537$34
Dorzolamide-Timolol16$451$28
Erythromycin12$140$12

2017: 4 drugs

Part D drugs prescribed in 2017
Timolol Maleate14$1,039$74
Prednisolone Acetate21$866$41
Dorzolamide-Timolol21$509$24
Latanoprost12$206$17

2016: 1 drug

Part D drugs prescribed in 2016
Erythromycin12$155$13

Money from drug and device companies

$385 in 2025

Industry payments by year
202547None$385
2024812$1,788$2,156
20231020$5,300$6,056
2022517$6,345$7,854
202135None$499
202011$350$350
2019511None$1,741

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Alcon VisionHydrus Microstent$159
1 payment
  • Meals for Hydrus Microstent · 2025-06-17 · $159
Regeneron Healthcare SolutionsEylea Hd$115
3 payments
  • Meals for Eylea Hd · 2025-07-08 · $40
  • Meals for Eylea Hd · 2025-05-12 · $36
  • Meals for Eylea Hd · 2025-01-30 · $39
Genentech USAVabysmo$69
2 payments
  • Meals for Vabysmo · 2025-10-07 · $35
  • Meals for Vabysmo · 2025-08-11 · $34
Regeneron PharmaceuticalsEylea Hd$42
1 payment
  • Meals for Eylea Hd · 2025-01-16 · $42
See all 7 published payments
Every published payment
Genentech USAMeals · 2025-10-07Vabysmo$35
Genentech USAMeals · 2025-08-11Vabysmo$34
Regeneron Healthcare SolutionsMeals · 2025-07-08Eylea Hd$40
Alcon VisionMeals · 2025-06-17Hydrus Microstent$159
Regeneron Healthcare SolutionsMeals · 2025-05-12Eylea Hd$36
Regeneron Healthcare SolutionsMeals · 2025-01-30Eylea Hd$39
Regeneron PharmaceuticalsMeals · 2025-01-16Eylea Hd$42
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $2,156

Payments by company in 2024
Carl Zeiss MeditecCirrus 6000 With Angioplex$1,138
2 payments
  • Consulting for Cirrus 6000 With Angioplex · 2024-09-05 · $650
  • Consulting for Cirrus Hd-Oct · 2024-04-24 · $488
Carl Zeiss Meditec USACirrus Hd-Oct$650
1 payment
  • Consulting for Cirrus Hd-Oct · 2024-01-09 · $650
Genentech USAVabysmo$119
4 payments
  • Meals for Vabysmo · 2024-09-23 · $34
  • Meals for Vabysmo · 2024-07-24 · $29
  • Meals for Vabysmo · 2024-05-29 · $29
  • Meals for Vabysmo · 2024-03-27 · $27
RxSightRxsight Contact Lens$114
1 payment
  • Meals for Rxsight Contact Lens · 2024-06-12 · $114
Regeneron PharmaceuticalsEylea$63
1 payment
  • Meals for Eylea · 2024-08-06 · $63
Apellis PharmaceuticalsSyfovre$25
1 payment
  • Meals for Syfovre · 2024-04-10 · $25
Alimera SciencesYutiq$24
1 payment
  • Meals for Yutiq · 2024-05-14 · $24
EisaiLenvima$23
1 payment
  • Meals for Lenvima · 2024-02-05 · $23

2023: $6,056

Payments by company in 2023
Carl Zeiss MeditecCirrus Hd-Oct$5,300
3 payments
  • Honoraria for Cirrus Hd-Oct · 2023-10-22 · $100
  • Consulting for Cirrus Hd-Oct · 2023-04-25 · $2,600
  • Paid to speak or teach for Cirrus Hd-Oct · 2023-04-25 · $2,600
Genentech USAVabysmo$260
5 payments
  • Meals for Vabysmo · 2023-12-21 · $26
  • Meals · 2023-11-25 · $149
  • Meals for Vabysmo · 2023-10-02 · $35
  • Meals for Vabysmo · 2023-06-07 · $25
  • Meals for Vabysmo · 2023-05-17 · $25
Oculus SurgicalNone$183
2 payments
  • Meals · 2023-10-11 · $137
  • Meals · 2023-09-28 · $45
Regeneron PharmaceuticalsEylea$100
2 payments
  • Meals for Eylea Hd · 2023-08-31 · $25
  • Meals for Eylea · 2023-04-03 · $74
AbbVieOzurdex$65
2 payments
  • Meals for Ozurdex · 2023-08-24 · $34
  • Meals for Ozurdex · 2023-05-09 · $31
Apellis PharmaceuticalsSyfovre$52
2 payments
  • Meals for Syfovre · 2023-07-19 · $24
  • Meals for Syfovre · 2023-03-14 · $29
Regeneron Healthcare SolutionsEylea$33
1 payment
  • Meals for Eylea · 2023-04-21 · $33
Bausch & Lomb AmericasXipere$24
1 payment
  • Meals for Xipere · 2023-05-02 · $24
Alcon VisionCenturion$22
1 payment
  • Meals for Centurion · 2023-08-08 · $22
Carl Zeiss Meditec USACirrus Hd-Oct$18
1 payment
  • Meals for Cirrus Hd-Oct · 2023-12-18 · $18

2022: $7,854

Payments by company in 2022
Genentech USAVabysmo$7,497
11 payments
  • Meals for Vabysmo · 2022-12-06 · $27
  • Travel for Vabysmo · 2022-12-03 · $101
  • Meals for Vabysmo · 2022-12-03 · $19
  • Travel for Vabysmo · 2022-12-03 · $375
  • Meals for Vabysmo · 2022-12-03 · $264
  • Travel for Vabysmo · 2022-12-03 · $293
  • Consulting for Vabysmo · 2022-12-03 · $6,345
  • Meals for Vabysmo · 2022-10-05 · $7
  • Meals for Vabysmo · 2022-08-11 · $26
  • Meals for Vabysmo · 2022-05-16 · $18
  • Meals for Vabysmo · 2022-03-22 · $23
GenentechSusvimo$169
2 payments
  • Meals for Vabysmo · 2022-11-11 · $35
  • Meals for Susvimo · 2022-04-19 · $135
Apellis PharmaceuticalsNone$124
1 payment
  • Meals · 2022-09-21 · $124
Regeneron Healthcare SolutionsEylea$45
2 payments
  • Meals for Eylea · 2022-12-13 · $23
  • Meals for Eylea · 2022-04-07 · $22
Alimera SciencesIluvien$19
1 payment
  • Meals for Iluvien · 2022-09-20 · $19

2021: $499

Payments by company in 2021
Genentech USALucentis$235
2 payments
  • Meals · 2021-12-05 · $111
  • Meals for Lucentis · 2021-08-19 · $124
GlaukosIstent Inject W$137
2 payments
  • Meals for Istent Inject W · 2021-05-11 · $66
  • Meals for Istent Inject W · 2021-04-21 · $70
Regeneron Healthcare SolutionsEylea$127
1 payment
  • Meals for Eylea · 2021-06-08 · $127

2020: $350

Payments by company in 2020
Alimera SciencesIluvien$350
1 payment
  • Honoraria for Iluvien · 2020-05-02 · $350

2019: $1,741

Payments by company in 2019
Regeneron PharmaceuticalsEylea$913
3 payments
  • Meals for Eylea · 2019-09-24 · $107
  • Travel · 2019-04-13 · $400
  • Travel · 2019-04-13 · $406
Alcon VisionConstellation$520
5 payments
  • Meals for Constellation · 2019-12-16 · $98
  • Meals for Constellation · 2019-11-20 · $143
  • Meals · 2019-03-26 · $133
  • Meals for Constellation · 2019-02-22 · $127
  • Meals for Constellation · 2019-02-16 · $19
Topcon Medical SystemsOct Triton$252
1 payment
  • Meals for Oct Triton · 2019-02-10 · $252
Alimera SciencesIluvien$35
1 payment
  • Meals for Iluvien · 2019-04-17 · $35
CelgeneNone$21
1 payment
  • Meals · 2019-05-06 · $21

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Regeneron Pharmaceuticals, Inc. · A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Tolerability of Subcutaneously Administered Pozelimab in Combination With Cemdisiran Or Cemdisiran Alone in Participants With Geographic Atrophy Secondary To Age-Related Macular Degeneration · 2025This clinician$802

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
100.0 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1225443997
Licence
CA A174746, CT 65296California A174746: Current · expires 2027-09-30
Trained
Harvard Medical School, 2014
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207W00000X (207W00000X)
Mailing address
2495 Hospital Dr Ste 545, Mountain View, CA, 94040
NPI first listed
2014-06-21
NPI last updated
2022-08-10
NPI record certified
2022-08-10

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 40 Temple St, New Haven, CT, 06510